"Visiobiane Anti-age" Effects on Vision Parameters

PiLeJe

Status and phase: Completed; Phase 4

Conditions: Macular Pigment Optical Density

Treatments: Drug: vitamins; Drug: DHA; Drug: lutein

Study type: Interventional

Funder types: Industry

Identifiers

NCT00449917

P11

Details and patient eligibility

About

The purpose of this study is to determine the benefits of "Visiobiane Anti-age" dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.

Full description

Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15 subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age). They will be supplemented for 24 weeks

Sex: Male

Ages: 45 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy caucasian men
• age : 45-55
• BMI < 25

Exclusion criteria

• non healthy
• retinian and/or visual anomaly
• Ocular media not clear enough to allow good fundus photography

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind